BioArctic AB (publ)
BRCTF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $18 | $24 | $27 | $22 |
| - Cash | $1 | $1 | $1 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $17 | $23 | $26 | $21 |
| Revenue | $0 | $1 | $0 | $0 |
| % Growth | -58.2% | 169.8% | 886.3% | – |
| Gross Profit | $0 | $1 | $0 | -$0 |
| % Margin | 89.5% | 85.5% | 67.4% | -137.9% |
| EBITDA | -$0 | $0 | $0 | -$0 |
| % Margin | -82.1% | 47.9% | 1.8% | -546.8% |
| Net Income | -$0 | $0 | -$0 | -$0 |
| % Margin | -68.8% | 37.2% | -4.9% | -517.5% |
| EPS Diluted | -2 | 2.59 | -0.13 | -1.36 |
| % Growth | -177.2% | 2,092.3% | 90.4% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |